3Gipson DS ,Trachtman H, Kaskel FJ, et al. Clinical trial of focal segmental glomerulosclerosis in children and young aduhs[J].Kid- ney Int, 2011,80 (8) : 868-878.
5Tannock LR. Advances in the management of hyperlipidemia-in- duced atherosclerosis [ J ]. Expert Rev Cardiovasc Ther, 2008, 6 (3) :369-383.
6TietgeUJ. Hyperlipidemia and cardiovascular disease:inflammation, dyslipidemia, and atherosclerosis [ J ]. Curr Opin Lipidol, 2014, 25 ( 1 ) :94-95.
7Tsuang W, Navaneethan U, Ruiz L, et al. Hypertriglyceridemic pancreatitis: presentation and management [J]. Am J Gastroen- terol,2009, 104(4) :984-991.
8Hu P, Lu L, Hu B, et al. Characteristics of lipid metabolism under differenl urinary protein excretion in children with primary nephrotiesyndrome[ J ]. Scand J Clin Lab Invest, 2009, 69 (6) :680-686.
9van de Woestijne AP, Monajemi H, Kalkhoven E, et al. Adipose tis- sue dysfunction and hypertriglyceridemia: mechanisms and manage- ment [ J]. Obes Rev ,2011, 12(10) :829-840.
10Inami N,Nomura S, Shouzu A, et al. Effects of pitavastatin on adi- ponectin in patients with hyperlipidemia [ J I. Pathophysiol Haemost Thromb,2007, 36( 1 ) :1-8.
5Ibrahim SE,Abdel-Salam IE,Galal EN,et al.Histologicalpatterns of idiopathic steroid resistant nephritic syndromein Egyptian children:A single centre study[J].J Neuro-pathol,2013,2(1):53-60.
6Pincus KJ,Hynicka LM.Prophylaxis of thromboembolicevents in patients with nephritic syndrome[J].Ann Phar-macother,2013,47(5):725-734.
7Dhingra S,Kanitkar M,Sengupta P.Steroid resistant ne-phrotic syndrome in a child with chronic hepatitis B infec-tion[J].Med J Armed Forces India,2012,68(4):376-378.
